These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27797621)

  • 1. In This Issue: Translational Opportunities for Antibodies: Therapeutics, Biomarkers, and Novel Targets.
    Bot A; Kumar H
    Int Rev Immunol; 2016 Jul; 35(4):291-293. PubMed ID: 27797621
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of monoclonal antibodies in therapeutics. Conclusion].
    Monier R
    C R Biol; 2006 Apr; 329(4):263-4. PubMed ID: 16644497
    [No Abstract]   [Full Text] [Related]  

  • 3. Progress and opportunities for immune therapeutics in osteosarcoma.
    Lettieri CK; Appel N; Labban N; Lussier DM; Blattman JN; Hingorani P
    Immunotherapy; 2016 Oct; 8(10):1233-44. PubMed ID: 27605071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges and opportunities for monoclonal antibody therapy in veterinary oncology.
    Beirão BC; Raposo T; Jain S; Hupp T; Argyle DJ
    Vet J; 2016 Dec; 218():40-50. PubMed ID: 27938708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future of immunotherapy drug combinations and biomarkers.
    Schmidt C
    J Natl Cancer Inst; 2012 Mar; 104(6):434-9. PubMed ID: 22402694
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunotherapy in prostate cancer: challenges and opportunities.
    Noguchi M; Koga N; Moriya F; Itoh K
    Immunotherapy; 2016; 8(1):69-77. PubMed ID: 26642100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian carcinoma therapy with monoclonal antibodies.
    Canevari S; Miotti S; Bottero F; Valota O; Colnaghi MI
    Hybridoma; 1993 Oct; 12(5):501-7. PubMed ID: 8300122
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoclonal antibody therapeutics: history and future.
    Buss NA; Henderson SJ; McFarlane M; Shenton JM; de Haan L
    Curr Opin Pharmacol; 2012 Oct; 12(5):615-22. PubMed ID: 22920732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman RA
    Biotechniques; 2005 Oct; 39(4):565-8. PubMed ID: 16235569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunotherapy--nursing requirements--presentation of care in immunotherapy with monoclonal antibodies as a part of the treatment of metastasized neuroblastoma IV].
    Lehner C
    Kinderkrankenschwester; 1998 Nov; 17(11):476-80. PubMed ID: 9887744
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of monoclonal antibodies in the immunotherapy of neoplasms].
    Robak T
    Przegl Lek; 1989; 46(4):420-6. PubMed ID: 2672121
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunotherapy with monoclonal antibody of malignant lymphoma].
    Ogura M
    Nihon Rinsho; 2007 Jan; 65 Suppl 1():545-60. PubMed ID: 17474462
    [No Abstract]   [Full Text] [Related]  

  • 13. A New Immunotherapy Drug Creates a Watershed for the Surgical Pathologist's Role in Patient Care.
    Cagle PT; Bernicker EH
    Arch Pathol Lab Med; 2015 Nov; 139(11):1329. PubMed ID: 26516934
    [No Abstract]   [Full Text] [Related]  

  • 14. Preface.
    Tainsky MA; Morris RT
    Cancer Metastasis Rev; 2015 Mar; 34(1):3. PubMed ID: 25648358
    [No Abstract]   [Full Text] [Related]  

  • 15. Antitumor antibodies for immunotherapy of ovarian carcinomas.
    Wagner U
    Hybridoma; 1993 Oct; 12(5):521-8. PubMed ID: 8300125
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor-associated antigens and biomarkers in cancer and immune therapy.
    Malyankar UM
    Int Rev Immunol; 2007; 26(3-4):223-47. PubMed ID: 17558745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bispecific antibodies for viral immunotherapy.
    Nyakatura EK; Soare AY; Lai JR
    Hum Vaccin Immunother; 2017 Apr; 13(4):836-842. PubMed ID: 27786606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction: Cancer Immunology Special Issue-Immunotherapy.
    Kawakami Y
    Int Immunol; 2016 Jul; 28(7):317. PubMed ID: 27313100
    [No Abstract]   [Full Text] [Related]  

  • 19. Technological Evolution in the Development of Therapeutic Antibodies.
    Fajardo-Ramírez ÓR; Ascacio-Martínez JA; Licea-Navarro AF; Villela-Martínez LM; Barrera-Saldaña HA
    Rev Invest Clin; 2015; 67(3):158-69. PubMed ID: 26202739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-specific antibodies for cancer immunotherapy.
    Jachimowicz RD; Borchmann S; Rothe A
    BioDrugs; 2014 Aug; 28(4):331-43. PubMed ID: 24638872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.